← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Director Jason P Rhodes sold $4.5M of Replimune Group, Inc.

Sold$4,494,442
$43.35Price
103,686Shares
−82%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Thu, Dec 10. Filed Mon, Dec 14, 7:20 PM ET, after the close. Not investment advice.